FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3165276656> ?p ?o ?g. }

• W3165276656 endingPage "E9" @default.
• W3165276656 startingPage "E9" @default.
• W3165276656 abstract "OBJECTIVE Bisphosphonates and teriparatide are the most common therapies used in the treatment of osteoporosis. Their impact on fusion rates in osteoporotic patients following spinal fusion has yet to be concretely defined, with previous systematic reviews focusing heavily on bisphosphonates and lacking clinical insight on the utility of teriparatide. Herein the authors present an updated meta-analysis of the utility of both bisphosphonates and teriparatide in improving spinal fusion outcomes in osteoporotic patients. METHODS After a comprehensive search of the English-language literature in the PubMed and Embase databases, 11 clinical studies were included in the final qualitative and quantitative analyses. Of these studies, 9 investigated bisphosphonates, 7 investigated teriparatide, and 1 investigated a combination of teriparatide and denosumab. Odds ratios and 95% confidence intervals were calculated where appropriate. RESULTS A meta-analysis of the postoperative use of bisphosphonate demonstrated better odds of successful fusion as compared to that in controls during short-term monitoring (OR 3.33, 95% CI 1.72–6.42, p = 0.0003) but not long-term monitoring (p > 0.05). Bisphosphonate use was also shown to significantly reduce the likelihood of postoperative vertebral compression fracture (VCF; OR 0.07, 95% CI 0.01–0.59, p = 0.01) and significantly reduce Oswestry Disability Index scores (mean difference [MD] = −2.19, 95% CI −2.94 to −1.44, p < 0.00001) and visual analog scale pain scores (MD = −0.58, 95% CI −0.79 to −0.38, p < 0.00001). Teriparatide was found to significantly increase fusion rates at long-term postoperative periods as compared to rates after bisphosphonate therapy, with patients who received postoperative teriparatide therapy 2.05 times more likely to experience successful fusion (OR 2.05, 95% CI 1.17–3.59, p = 0.01). CONCLUSIONS The authors demonstrate the benefits of bisphosphonate and teriparatide therapy independently in accelerating fusion during the first 6 months after spinal fusion surgery in osteoporotic patients. In addition, they show that teriparatide may have superior benefits in spinal fusion during long-term monitoring as compared to those with bisphosphonates. Bisphosphonates may be better suited in preventing VCFs postoperatively in addition to minimizing postoperative disability and pain." @default.
• W3165276656 created "2021-06-07" @default.
• W3165276656 creator A5003737045 @default.
• W3165276656 creator A5027931546 @default.
• W3165276656 creator A5053821773 @default.
• W3165276656 creator A5058043578 @default.
• W3165276656 creator A5082419762 @default.
• W3165276656 creator A5089389439 @default.
• W3165276656 date "2021-06-01" @default.
• W3165276656 modified "2023-10-17" @default.
• W3165276656 title "Osteoporosis treatment in patients undergoing spinal fusion: a systematic review and meta-analysis" @default.
• W3165276656 cites W1036610077 @default.
• W3165276656 cites W1493734536 @default.
• W3165276656 cites W1606867770 @default.
• W3165276656 cites W1971653242 @default.
• W3165276656 cites W1975923668 @default.
• W3165276656 cites W1989400609 @default.
• W3165276656 cites W1992896635 @default.
• W3165276656 cites W1993232754 @default.
• W3165276656 cites W2002645864 @default.
• W3165276656 cites W2011222615 @default.
• W3165276656 cites W2034427928 @default.
• W3165276656 cites W2040219651 @default.
• W3165276656 cites W2051110484 @default.
• W3165276656 cites W2060105026 @default.
• W3165276656 cites W2076950276 @default.
• W3165276656 cites W2089516127 @default.
• W3165276656 cites W2118576106 @default.
• W3165276656 cites W2128843508 @default.
• W3165276656 cites W2132089314 @default.
• W3165276656 cites W2138989054 @default.
• W3165276656 cites W2148506694 @default.
• W3165276656 cites W2153009489 @default.
• W3165276656 cites W2153368777 @default.
• W3165276656 cites W2160087292 @default.
• W3165276656 cites W2193423010 @default.
• W3165276656 cites W2316468335 @default.
• W3165276656 cites W2327824277 @default.
• W3165276656 cites W2592466058 @default.
• W3165276656 cites W2619448414 @default.
• W3165276656 cites W2753576231 @default.
• W3165276656 cites W2791019576 @default.
• W3165276656 cites W2792392055 @default.
• W3165276656 cites W2800067200 @default.
• W3165276656 cites W2879892081 @default.
• W3165276656 cites W2887117129 @default.
• W3165276656 cites W2887258070 @default.
• W3165276656 cites W2889539433 @default.
• W3165276656 cites W2935865486 @default.
• W3165276656 cites W2949823341 @default.
• W3165276656 cites W2953537933 @default.
• W3165276656 cites W2966130116 @default.
• W3165276656 cites W2976730718 @default.
• W3165276656 cites W3008295161 @default.
• W3165276656 cites W3037389099 @default.
• W3165276656 cites W4239669902 @default.
• W3165276656 cites W4361867782 @default.
• W3165276656 cites W4376595565 @default.
• W3165276656 doi "https://doi.org/10.3171/2021.3.focus2175" @default.
• W3165276656 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34062507" @default.
• W3165276656 hasPublicationYear "2021" @default.
• W3165276656 type Work @default.
• W3165276656 sameAs 3165276656 @default.
• W3165276656 citedByCount "10" @default.
• W3165276656 countsByYear W31652766562022 @default.
• W3165276656 countsByYear W31652766562023 @default.
• W3165276656 crossrefType "journal-article" @default.
• W3165276656 hasAuthorship W3165276656A5003737045 @default.
• W3165276656 hasAuthorship W3165276656A5027931546 @default.
• W3165276656 hasAuthorship W3165276656A5053821773 @default.
• W3165276656 hasAuthorship W3165276656A5058043578 @default.
• W3165276656 hasAuthorship W3165276656A5082419762 @default.
• W3165276656 hasAuthorship W3165276656A5089389439 @default.
• W3165276656 hasBestOaLocation W31652766561 @default.
• W3165276656 hasConcept C126322002 @default.
• W3165276656 hasConcept C141071460 @default.
• W3165276656 hasConcept C14184104 @default.
• W3165276656 hasConcept C142724271 @default.
• W3165276656 hasConcept C156957248 @default.
• W3165276656 hasConcept C204787440 @default.
• W3165276656 hasConcept C2775998654 @default.
• W3165276656 hasConcept C2776286101 @default.
• W3165276656 hasConcept C2776541429 @default.
• W3165276656 hasConcept C2776886416 @default.
• W3165276656 hasConcept C2777251235 @default.
• W3165276656 hasConcept C2777308945 @default.
• W3165276656 hasConcept C2780375110 @default.
• W3165276656 hasConcept C2780907711 @default.
• W3165276656 hasConcept C44249647 @default.
• W3165276656 hasConcept C71924100 @default.
• W3165276656 hasConcept C95190672 @default.
• W3165276656 hasConceptScore W3165276656C126322002 @default.
• W3165276656 hasConceptScore W3165276656C141071460 @default.
• W3165276656 hasConceptScore W3165276656C14184104 @default.
• W3165276656 hasConceptScore W3165276656C142724271 @default.
• W3165276656 hasConceptScore W3165276656C156957248 @default.
• W3165276656 hasConceptScore W3165276656C204787440 @default.
• W3165276656 hasConceptScore W3165276656C2775998654 @default.

• next